Transgenic animal bioreactors can produce therapeutic proteins with high value for
pharmaceutical use. In this paper, we compared different systems capable of producing …

Since the generation of the first transgenic mice in 1980, transgene technology has also
been successfully applied to large farm animals. Although this technology can be employed …

The recombinant production of therapeutic proteins for human diseases is currently the
largest source of innovation in the pharmaceutical industry. The market growth has been the …

1. Although many human therapeutic proteins are currently produced in microbial fermentors
using recombinant DNA techniques, it is obvious that microbial processing is not suitable for …

Transgenic animal bioreactors represent a powerful tool to address the growing need for
therapeutic recombinant proteins. The ability of transgenic animals to produce complex …

The production of recombinant proteins is one of the major successes of biotechnology.
Animal cells are required to synthesize proteins with the appropriate post-translational …

The ability to modify mammary gland function through genetic engineering provides an
opportunity to investigate mechanism of breast cancer, enhance the nutritional quality of milk …

Transgenic livestock that produce recombinant proteins in their milk can provide an
economic and safe system for production of valuable proteins, such as pharmaceutical …

The expression of therapeutically useful proteins in transgenic animals is a field of
biotechnology that is now coming of age. Over the past few years, significant progress has …

Gene fanning is one of the most promising areas in modern biotechnology. To assay the
potential usefulness of transgenic rabbits as bioreactors, one cell embryos were …